<bill session="118" type="h" number="2666" updated="2025-05-27T14:14:23Z">
  <state datetime="2023-05-24">REPORTED</state>
  <status>
    <unknown datetime="2023-05-24"/>
  </status>
  <introduced datetime="2023-04-18"/>
  <titles>
    <title type="display">Medicaid VBPs for Patients Act</title>
    <title type="short" as="introduced">Medicaid VBPs for Patients Act</title>
    <title type="short" as="introduced">MVP Act</title>
    <title type="short" as="reported to house">Medicaid VBPs for Patients Act</title>
    <title type="official" as="introduced">To amend title XIX of the Social Security Act to codify value-based purchasing arrangements under the Medicaid program and reforms related to price reporting under such arrangements, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="G000558"/>
  <cosponsors>
    <cosponsor bioguide_id="A000148" joined="2023-04-18"/>
    <cosponsor bioguide_id="B001306" joined="2023-05-22"/>
    <cosponsor bioguide_id="B001287" joined="2023-07-10"/>
    <cosponsor bioguide_id="B001257" joined="2023-05-15"/>
    <cosponsor bioguide_id="B001275" joined="2023-12-12"/>
    <cosponsor bioguide_id="B001248" joined="2023-12-14"/>
    <cosponsor bioguide_id="C001039" joined="2024-06-25"/>
    <cosponsor bioguide_id="C001134" joined="2024-02-28"/>
    <cosponsor bioguide_id="C001103" joined="2023-10-02"/>
    <cosponsor bioguide_id="C001125" joined="2023-11-06"/>
    <cosponsor bioguide_id="C001133" joined="2024-02-09"/>
    <cosponsor bioguide_id="C001120" joined="2023-05-11"/>
    <cosponsor bioguide_id="D000230" joined="2023-12-12"/>
    <cosponsor bioguide_id="D000615" joined="2024-04-16"/>
    <cosponsor bioguide_id="D000628" joined="2023-05-17"/>
    <cosponsor bioguide_id="E000215" joined="2023-04-18"/>
    <cosponsor bioguide_id="F000465" joined="2023-11-07"/>
    <cosponsor bioguide_id="G000583" joined="2023-11-01"/>
    <cosponsor bioguide_id="H001090" joined="2023-12-05"/>
    <cosponsor bioguide_id="H001085" joined="2023-09-14"/>
    <cosponsor bioguide_id="H001068" joined="2023-11-14"/>
    <cosponsor bioguide_id="I000058" joined="2023-12-22"/>
    <cosponsor bioguide_id="J000302" joined="2023-04-18"/>
    <cosponsor bioguide_id="K000376" joined="2024-01-03"/>
    <cosponsor bioguide_id="L000582" joined="2023-07-17"/>
    <cosponsor bioguide_id="M000317" joined="2024-04-30"/>
    <cosponsor bioguide_id="M001204" joined="2024-02-05"/>
    <cosponsor bioguide_id="M001215" joined="2023-04-18"/>
    <cosponsor bioguide_id="M001194" joined="2024-02-05"/>
    <cosponsor bioguide_id="M001225" joined="2023-11-15"/>
    <cosponsor bioguide_id="O000086" joined="2024-01-31"/>
    <cosponsor bioguide_id="P000608" joined="2023-04-18"/>
    <cosponsor bioguide_id="P000620" joined="2023-11-28"/>
    <cosponsor bioguide_id="P000616" joined="2023-06-30"/>
    <cosponsor bioguide_id="S001189" joined="2024-01-11"/>
    <cosponsor bioguide_id="S001207" joined="2023-08-22"/>
    <cosponsor bioguide_id="S001135" joined="2024-04-30"/>
    <cosponsor bioguide_id="S001159" joined="2024-09-24"/>
    <cosponsor bioguide_id="S001193" joined="2023-05-11"/>
    <cosponsor bioguide_id="T000460" joined="2023-08-01"/>
    <cosponsor bioguide_id="V000133" joined="2024-04-09"/>
    <cosponsor bioguide_id="V000134" joined="2024-06-25"/>
  </cosponsors>
  <actions>
    <action datetime="2023-04-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-04-18" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2023-04-18">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2023-05-15">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2023-05-17">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2023-05-17">
      <text>Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 16 - 11 .</text>
    </action>
    <action datetime="2023-05-24">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2023-05-24" state="REPORTED">
      <text>Ordered to be Reported (Amended) by the Yeas and Nays: 31 - 19.</text>
    </action>
    <action datetime="2024-11-18">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-743, Part I.</text>
    </action>
    <action datetime="2024-11-18">
      <text>House Committee on Ways and Means Granted an extension for further consideration ending not later than Dec. 19, 2024.</text>
    </action>
    <action datetime="2024-12-17">
      <text>Referred to the Subcommittee on Work and Welfare.</text>
    </action>
    <action datetime="2024-12-19">
      <text>Committee on Ways and Means discharged.</text>
    </action>
    <calendar datetime="2024-12-19" calendar="Union" number="768">
      <text>Placed on the Union Calendar, Calendar No. 768.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Discharged From, Unknown, Referred To"/>
    <committee code="HSWM03" name="House Ways and Means" subcommittee="Work and Welfare" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Reported By, Markup By, Referred To"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Intergovernmental relations"/>
    <term name="Medicaid"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2023-11-29T17:11:10Z" status="Introduced in House">Medicaid VBPs for Patients Act or the MVP Act

This bill provides statutory authority for regulations that allow for the use of varying best price points under value-based purchasing arrangements for purposes of the Medicaid Drug Rebate Program. (Value-based purchasing arrangements refer to arrangements in which the price of a drug is linked to clinical outcomes; such arrangements are particularly used for new high-cost treatments, such as gene therapies.)

The Government Accountability Office must study the impact of value-based purchasing arrangements on federal health care programs, including with respect to the bill's changes.

Additionally, the bill (1) exempts sales of drugs that are made under value-based purchasing arrangements from calculations of the manufacturer average sales price for purposes of payments under Medicare medical services, if the manufacturer reports multiple best prices under Medicaid in accordance with the bill's changes; and (2) requires the Centers for Medicare &amp; Medicaid Services to establish a program under which state Medicaid programs may cover drugs in inpatient settings via value-based purchasing arrangements.

The bill's changes terminate five years after enactment; any value-based purchasing arrangements that are in effect as of the date of termination continue to apply.</summary>
  <committee-reports>
    <report>H. Rept. 118-743</report>
  </committee-reports>
</bill>
